Oil Surge Drags Nasdaq, While Cybersecurity Names Rally on AI Safety Warnings | MarketReader Minute
U.S. equity markets decline amid rising oil prices and AI slowdown fears, while Canada’s inflation holds steady at 3% and the U.S. dollar strengthens ahead of anticipated Fed interest rate hike.
Welcome to the MarketReader Minute.
Below are AI-generated insights on today's premarket moves, powered by MarketReader technology.

Monday, September 14
Noteworthy macro moves today: EUR/USD -0.6%. Nasdaq 100 Index (US) -1.8%. USD/JPY +0.8%. Noteworthy US mega-cap moves today: SK Hynix Inc (SKHY) -7.4%. Intel Corp (INTC) -6.8%. Micron Technology Inc (MU) -6.0%.
Global equity markets are mixed, with U.S. indices trading lower while Asian markets show some resilience. The Nasdaq 100 Index has fallen sharply by 1.8%, reflecting concerns over rising oil prices and the potential impact of a slowdown in artificial intelligence development on tech stocks. In Japan, industrial production data released today showed a decline of 0.2% for July, significantly below expectations of a slight increase, which has contributed to negative sentiment in the region.
In Canada, inflation data released this morning indicated that the headline inflation rate held steady at 3% for August, aligning with market forecasts and suggesting stability amid ongoing energy price pressures from geopolitical tensions in the Middle East. Core inflation ticked up to 2.4% from 2.3%, a marginal increase that leaves underlying price pressures broadly contained despite external shocks.
The U.S. dollar is experiencing strength today, surging to a near two-week high as traders price in an anticipated interest rate hike by the Federal Reserve later this week following last week's inflation report showing persistent price growth at 3.4%. This expectation is further supported by rising crude oil prices and sticky inflation data that have raised concerns about future monetary policy adjustments.
In commodities, oil prices have surged sharply due to supply concerns following Saudi Arabia's pipeline shutdown after recent drone attacks, contributing to broader market volatility and impacting sectors sensitive to energy costs.

iShares MSCI South Korea ETF (EWY) [-4.6%]
Pre-market trading for iShares MSCI South Korea ETF has shown a notable decline, driven by significant negative performance among its top holdings. SKHY dropped 7.15%, contributing -1.74% to the ETF's performance, while SKM and KEP also experienced losses. The ETF is further influenced by a downturn in the Nasdaq 100 Index, which is lower since Friday's close due to rising crude oil prices following Saudi Arabia's closure of its East-West pipeline amid security concerns. Additionally, expectations for an interest rate hike by the Federal Reserve are weighing on market performance. Overall, the iShares MSCI South Korea ETF is lower as it reflects broader market pressures and specific challenges within its holdings.
VanEck Semiconductor ETF (SMH) [-4.6%]
The VanEck Semiconductor ETF is experiencing a decline in pre-market trading as global semiconductor revenue reached a record $425 billion in the second quarter of 2026, driven by strong demand for AI and memory components. However, Asian stock markets are lower due to surging crude oil prices following Saudi Arabia's closure of a critical East-West pipeline after drone attacks. This situation has raised concerns about energy security and inflation, contributing to the ETF's downward movement. The Nasdaq 100 Index is also lower, influenced by these same factors, which may be impacting SMH's performance. Notably, significant declines among major holdings, including NVIDIA and Lam Research, are further weighing on the ETF.
Global X Copper Miners ETF (COPX) [-2.7%]
Pre-market trading for Global X Copper Miners ETF has shown a notable decline, influenced by significant losses among its top holdings. Key contributors to this downward movement include Freeport-McMoRan, which fell 4.4%, and Hudbay Minerals, down 3.85%. Other major holdings such as BHP, Southern Copper Corporation, and Ero Copper also experienced declines ranging from 3.18% to 3.2%. Additionally, the ETF's performance appears to be moving in sympathy with the United States Copper Index Fund, which is lower amid a stronger U.S. dollar and expectations of a potential interest rate hike by the Federal Reserve. Overall, the ETF is trading lower since Friday's close, reflecting ongoing weakness in the copper mining sector.

PANW | +4.8% | +13.4B
Palo Alto Networks Inc | Information Technology
Palo Alto Networks shares gained traction in pre-market trading, reflecting a broader rally in cybersecurity stocks. This surge follows alarming warnings from AI leaders at Anthropic and OpenAI regarding potential risks associated with advancements in artificial intelligence. As concerns over AI safety escalate, organizations are expected to prioritize infrastructure protection, benefiting companies in the cybersecurity sector. Notably, shares of Palo Alto Networks advanced sharply, aligning with other major players in the field. CEO Nikesh Arora highlighted the company's cloud infrastructure strategy, noting an annual expenditure of over $1 billion on cloud services without operating its own data centers. This operational approach underscores the scale at which Palo Alto Networks processes data, with 19 petabytes flowing through Google Cloud daily.
CRWD | +5.4% | +12.0B
CrowdStrike Holdings Inc | Information Technology
Cybersecurity stocks are experiencing significant gains in pre-market trading, driven by heightened concerns regarding AI risks voiced by leaders from Anthropic and OpenAI. CrowdStrike Holdings Inc shares advanced sharply amid this trend, reflecting increased demand for cybersecurity solutions as organizations seek to bolster their defenses against evolving threats. Additionally, CrowdStrike filed for an offering of up to 2,118,022 shares of common stock by a selling stockholder, which will not generate proceeds for the company. Despite this offering, the stock is gaining traction as market sentiment favors cybersecurity firms in light of recent developments.
GSK | +4.0% | +8.2B
GSK plc | Health Care
GSK plc reported positive clinical results for its investigational lung cancer therapies, contributing to the stock's rise during pre-market hours. The company announced that Jideytro achieved its primary endpoints in a Phase I/II trial, demonstrating a 94% objective response rate in previously untreated patients with ROS1-positive non-small cell lung cancer. Additionally, Ris-Rez, licensed from Hansoh Pharmaceuticals, showed a significant 54% reduction in the risk of death compared to standard chemotherapy in patients with relapsed small cell lung cancer. These developments have generated positive investor sentiment, supporting GSK's upward movement since Friday's close.
NOW | +4.6% | +6.6B
ServiceNow Inc | Information Technology
ServiceNow Inc is experiencing gains during pre-market hours, buoyed by positive sentiment in the software sector. Posts indicate that ServiceNow's price increased alongside other companies such as Salesforce, Atlassian, and CrowdStrike, which also reported notable rises. This upward movement may be further supported by the strong performance of Freshworks Inc, which has gained sharply following an Overweight rating and a price target increase from KeyBanc analyst Jackson Ader. Additionally, analysts have raised their price targets for ServiceNow, with Needham & Company increasing theirs from $115 to $155, while BTIG Research raised its target from $150 to $170. Despite these gains, earlier in the session, ServiceNow shares pulled back from a session high.
BNTX | +6.1% | +1.6B
Biontech SE | Health Care
BioNTech SE's stock is advancing sharply in pre-market trading following the release of promising clinical trial data for its investigational drug gotistobart. The updated results from the PRESERVE-003 Phase 3 trial revealed that the median overall survival for patients with previously treated squamous non-small cell lung cancer receiving gotistobart was 18.5 months, compared to 10.0 months for those undergoing standard chemotherapy, with a hazard ratio of 0.56. This data was presented at the International Association for the Study of Lung Cancer's 2026 World Conference on Lung Cancer, underscoring gotistobart's potential to enhance treatment options for patients with limited alternatives.
Thank you for spending a minute with us.
If you have 2 more minutes, watch this demo of the MarketReader Platform:

